{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T21:08:09Z","timestamp":1786655289791,"version":"build-2736575974"},"reference-count":55,"publisher":"Informa UK Limited","issue":"16","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pharmacogenomics"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.2217\/pgs.15.125","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T17:55:18Z","timestamp":1447178118000},"page":"1781-1793","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":48,"title":["Cost\u2013Effectiveness Analysis of Genotyping for\n            <i>HLA-B*5801<\/i>\n            and an Enhanced Safety Program in Gout Patients Starting Allopurinol in Singapore"],"prefix":"10.1080","volume":"16","author":[{"given":"Di","family":"Dong","sequence":"first","affiliation":[{"name":"Health Services &amp; Systems Research Program, Duke-NUS Graduate Medical School, 8 College Road, Singapore 169857, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chuen","family":"Tan-Koi","sequence":"additional","affiliation":[{"name":"Vigilance &amp; Compliance Branch, Health Sciences Authority, 11 Biopolis Way, #11\u201301, Helios, Singapore 138667, Singapore"},{"name":"Saw Swee Hock School of Public Health, National University of Singapore, Tahir Foundation Building, 12 Science Drive 2, #10\u201301, Singapore 117549, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gim Gee","family":"Teng","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, National University Health System, University Medicine Cluster, Singapore"},{"name":"Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Finkelstein","sequence":"additional","affiliation":[{"name":"Health Services &amp; Systems Research Program, Duke-NUS Graduate Medical School, 8 College Road, Singapore 169857, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Sung","sequence":"additional","affiliation":[{"name":"Vigilance &amp; Compliance Branch, Health Sciences Authority, 11 Biopolis Way, #11\u201301, Helios, Singapore 138667, Singapore"},{"name":"Emerging Infectious Diseases Program, Duke-NUS Graduate Medical School, 8 College Road, Singapore 169857, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2015,11,10]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2011.08.004"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21772"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.055269"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2005.00790.x"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.08.036"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512143332404"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5701033"},{"key":"e_1_3_3_9_1","unstructured":"Singapore Health Sciences Authority . Serious skin reactions associated with allopurinol. Adverse Drug Reactions News (2009) . www.hsa.gov.sg\/content\/hsa\/en\/Health_Products_Regulation\/Safety_Information_and_Product_Recalls\/Product_Safety_Alerts\/2009\/serious_skin_reactions.html"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.burns.2014.02.006"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411103311906"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.9.11.1617"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e328330a3b8"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-12-118"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr060"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409500102"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.11.131"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2012.209"},{"key":"e_1_3_3_19_1","unstructured":"European Medicine Agency CFMPFHU Pharmacovigilance Working Party . Allopurinol: risk of skin reactions associated with HLA-B*5801 allele. Pharmacovigilance Working Party (PhVWP) monthly report on safety concerns guidelines and general matters. EMA\/CHMP\/PhVWP\/438980\/2012.www.ema.europa.eu\/docs\/en_GB\/document_library\/Report\/2012\/07\/WC500130391.pdf"},{"key":"e_1_3_3_20_1","unstructured":"Taiwan Food and Drug Administration . Drug Safety News (2009) . www.fda.gov.tw\/tc\/siteListContent.aspx?sid=1571&id=7616&chk=1197ef3b-eda3-4a7b-95e0-7c6e7013d32e\u00b6m=pn%3D69%26sid%3D1571#.VGtc8vmUd9g"},{"key":"e_1_3_3_21_1","unstructured":"dbMHC database . www.ncbi.nlm.nih.gov\/projects\/gv\/mhc\/ihwg.cgi"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.136.3.323"},{"key":"e_1_3_3_23_1","volume-title":"Textbook of Rheumatology.","author":"Firestein GS","year":"1997","unstructured":"Firestein GS , KelleyW , RuddyS , HarrisE , SledgeC . Textbook of Rheumatology.WB Saunders , PA, USA ( 1997 )."},{"key":"e_1_3_3_24_1","unstructured":"Singapore Department of Statistics . Life expectancy at birth . www.singstat.gov.sg\/statistics\/visualising_data\/chart\/Life_Expectancy_At_Birth.html"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem056a"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.4065\/81.7.925"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.091462"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2009.236"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.083071"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-013-0084-0"},{"key":"e_1_3_3_31_1","first-page":"1","article-title":"Stevens\u2013Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in Sarawak: a four years\u2019 review","volume":"4","author":"Yap F","year":"2008","unstructured":"Yap F , WahiduzzamanMPubalanM . Stevens\u2013Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in Sarawak: a four years\u2019 review . Egypt. Dermatol. Online J.4 , 1 \u2013 13 ( 2008 ).","journal-title":"Egypt. Dermatol. Online J."},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.bcr.0000194268.01514.f8"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2006.01295.x"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2009.540"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31826aac73"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037711"},{"issue":"5","key":"e_1_3_3_37_1","first-page":"453","article-title":"cost\u2013effectiveness of febuxostat in chronic gout","volume":"15","author":"Beard S","year":"2013","unstructured":"Beard S , ScheeleB , NukiG , PearsonI . cost\u2013effectiveness of febuxostat in chronic gout . Eur. J. Health Econ.15 ( 5 ), 453 \u2013 463 ( 2013 ).","journal-title":"Eur. J. Health Econ."},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(03)00462-7"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24209"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050373"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.121301"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddu149"},{"key":"e_1_3_3_43_1","unstructured":"Singapore Pharmacogenomics Portal . www.statgen.nus.edu.sg\/~SPGx\/SPGx_Main.php"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.5415\/apallergy.2013.3.4.215"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes253"},{"key":"e_1_3_3_46_1","unstructured":"Monetary Authority of Singapore . Foreign exchange rates . https:\/\/secure.mas.gov.sg\/msb\/ExchangeRates.aspx"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1586\/14737167.8.2.165"},{"key":"e_1_3_3_48_1","unstructured":"How NICE measures value for money in relation to public health interventions . http:\/\/publications.nice.org.uk\/how-nice-measures-value-for-money-in-relation-to-public-health-interventions-lgb10b\/nices-approach-to-economic-analysis-for-public-health-interventions"},{"key":"e_1_3_3_49_1","unstructured":"US Food Drug Administration . Uloric Safety Labeling Changes Approved by FDA Centre for Drug Evaluation and Research (CDER) . www.fda.gov\/safety\/medwatch\/safetyinformation\/ucm243770.htm"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22409"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780290111"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204463"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.070755"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201687"},{"issue":"5","key":"e_1_3_3_55_1","first-page":"384","article-title":"Allopurinol hypersensitivity syndrome: a preventable severe cutaneous adverse reaction?","volume":"49","author":"Lee HY","year":"2008","unstructured":"Lee HY , AriyasingheJT , ThirumoorthyT . Allopurinol hypersensitivity syndrome: a preventable severe cutaneous adverse reaction?Singapore Med. J.49 ( 5 ), 384 \u2013 387 ( 2008 ).","journal-title":"Singapore Med. J."},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.3536"}],"container-title":["Pharmacogenomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/pgs.15.125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T14:30:53Z","timestamp":1715956253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/pgs.15.125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":55,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.2217\/pgs.15.125"],"URL":"https:\/\/doi.org\/10.2217\/pgs.15.125","relation":{},"ISSN":["1462-2416","1744-8042"],"issn-type":[{"value":"1462-2416","type":"print"},{"value":"1744-8042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-11-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}